Kolexia
Vuagnat Perrine Oncologie médicale
Vuagnat Perrine
Oncologie médicale
Centre Eugène Marquis
Rennes, France
73 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein COVID-19 Instabilité des microsatellites Tumeurs du poumon Tumeurs colorectales Tumeurs du sein triple-négatives Tumeurs de la prostate Carcinomes Carcinome pulmonaire non à petites cellules

Collaborateurs

Voir plus
Massard Christophe
Massard Christophe
Gustave-Roussy, Villejuif, France
Hollebecque Antoine
Hollebecque Antoine
Gustave-Roussy, Villejuif, France
Baldini Capucine
Baldini Capucine
Gustave-Roussy, Villejuif, France
Champiat Stephane
Champiat Stephane
Gustave-Roussy, Villejuif, France

Industries

Voir plus
Novartis
3 collaboration(s)
Dernière en 2021
MSD
2 collaboration(s)
Dernière en 2023
MundiPharma
2 collaboration(s)
Dernière en 2021
Amgen
1 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
ePPS-2202: Phase 3 Superiority Trial Evaluating the Benefit of Dematerialized Information Media for Patients With Advanced Sarcomas Receiving Second Line Treatment.
Essai Clinique (Centre Oscar-Lambret)   24 janvier 2024
2158P A self-assessment survey to identify the risk of patient’s screen fail in phase I clinical trials (SCITEP trial)
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
Overcoming resistance to αPD-1 of MMR-deficient tumors with high tumor-induced neutrophils levels by combination of αCTLA-4 and αPD-1 blockers.
Journal for immunotherapy of cancer   14 septembre 2023
Atezolizumab and paclitaxel as first line therapy in advanced triple-negative breast cancer patients included in the French early access program.
Scientific reports   18 août 2023
COVID-19 in Breast Cancer Patients - Medscape
Medscape   15 mai 2023
Effectiveness of electronic patient reporting outcomes, by a digital telemonitoring platform, for prostate cancer care: the Protecty study.
Frontiers in digital health   08 mai 2023
PEMBIB: Phase Ib Trial Of Pembrolizumab And Nintedanib
Essai Clinique (Gustave-Roussy)   24 avril 2023
A Phase I Study of an IDO-1 Inhibitor (LY3381916) as Monotherapy and in Combination With an Anti-PD-L1 Antibody (LY3300054) in Patients With Advanced Cancer.
Journal of immunotherapy (Hagerstown, Md. : 1997)   12 avril 2023
COVID-19 in Breast Cancer Patients - Medscape
Medscape   09 mars 2023
86P Validation of the Gustave Roussy Immune (GRIm) score in patients treated with bispecific CD3 T cell engagers in phase I clinical trials
Abstract Book of the ESMO Targeted Anticancer Therapies Congress (TAT) 6-8 March 2023   01 mars 2023